diabetes treatment

New Study Finds No Thyroid Cancer Risk from GLP1 An image depicting Scandinavian healthcare data analysis involving patients and doctors, with a digital overlay showcasing medical records and cancer research in a modern clinical setting. The background shows serene Nordic landscapes with medical facilities and people representing different age groups, signifying population health studies.

An image depicting Scandinavian healthcare data analysis involving patients and doctors, with a digital overlay showcasing medical records and cancer research in a modern clinical setting. The background shows serene Nordic landscapes with medical facilities and people representing different age groups, signifying population health studies.

New Study Finds No Thyroid Cancer Risk from GLP1

Contributor September 25, 2024

This Scandinavian cohort study analyzed the potential link between GLP1 receptor agonists, used in type 2 diabetes...

Cutting Potassium Risk: A Breakthrough for Diabetes Patients High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

Cutting Potassium Risk: A Breakthrough for Diabetes Patients

Contributor September 23, 2024

This population-based cohort study investigates the relationship between the use of SGLT-2 inhibitors, GLP-1 receptor agonists, and...

Discover the Powerful Link Between Diabetes and Dementia Prevention A medical study scene showing two types of diabetes medication (SGLT-2 inhibitors vs. DPP-4 inhibitors) influencing brain health. The image should depict brain protection, neurons, and a futuristic approach to dementia prevention. Clear elements of healthcare, diabetes, and cognitive science.

A medical study scene showing two types of diabetes medication (SGLT-2 inhibitors vs. DPP-4 inhibitors) influencing brain health. The image should depict brain protection, neurons, and a futuristic approach to dementia prevention. Clear elements of healthcare, diabetes, and cognitive science.

Discover the Powerful Link Between Diabetes and Dementia Prevention

Contributor September 21, 2024

The study compares dementia risk in adults aged 40-69 with type 2 diabetes, following the use of...

Unlock Superior Diabetes Control: Boost Health & Confidence An advanced medical illustration showcasing the mechanism of GLP-1 receptor agonists in type 2 diabetes treatment. The image should depict a vibrant scientific scene with blood sugar regulation, weight loss, and lipid improvement visual cues, all in a clinical setting.

Unlock Superior Diabetes Control: Boost Health & Confidence

Contributor September 18, 2024

This systematic review and meta-analysis evaluates the comparative effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) for glycemic...